Status | Study |
Active, not recruiting |
Study Name: Acromegaly & Sleep Apnoea Condition: Acromegaly Date: 2015-02-11 |
Recruiting |
Study Name: Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues Condition: Acromegaly Date: 2015-02-04 Interventions: Drug: Sandostatin (Octreotide Acetate) For the patients ou |
Active, not recruiting |
Study Name: Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues Condition: Acromegaly Date: 2015-01-29 Interventions: Drug: Pasireotide LAR Pasireotide 40 mg and 60 mg. O |
Recruiting |
Study Name: Ga-68-DOTATOC -PET in the Management of Pituitary Tumours Condition: Pituitary Tumours Date: 2015-01-19 Interventions: Procedure: Gallium-68 DOTATOC PET The intervention is to administer Ga-68 DOTATOC in pituitary patients |
Completed |
Study Name: Phase II Study of Subcutaneous Injection Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) Condition: Acromegaly Neuroendocrine Tumors Date: 2014-11-17 Interventions: Drug: octreotide FluidCrystal® injection depot Other Name: CAM2029 |
Recruiting |
Study Name: Late Effects of Radiosurgery on Acromegaly Study Condition: Acromegaly Date: 2014-10-28 Interventions: Device: Gamma Knife radiosurgery To determine potential long-term (superior to 10 years) extra-pituitary |
Completed |
Study Name: Clomiphene Citrate for Treatment of Acromegaly Condition: Acromegaly Date: 2014-10-20 Interventions: Drug: Clomiphene Citrate Clomiphene citrate, 50 mg, orally for three months |
Completed |
Study Name: SAGIT for Classification of Patients With Acromegaly in Clinical Practice Condition: Acromegaly Date: 2014-09-02 Interventions: Other: SAGIT SAGIT is a Clinician-Reported Outcomes (ClinROs) tool |
Completed |
Study Name: Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients. Condition: Acromegaly Date: 2014-08-14 Interventions: Drug: saline Eligible patients |
Active, not recruiting |
Study Name: The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics Condition: Acromegaly Date: 2014-08-14 Interventions: Drug: saline Eligible patients |